Smoking Cessation in a Drug Treatment Program: A Randomized Trial of Varenicline Versus Placebo.
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 33
- 试验地点
- 1
- 主要终点
- quit smoking rating
研究概览
简要总结
The aim of this study is to assess the efficacy of varenicline compared to placebo in tobacco dependent individuals who are undergoing concurrent treatment for alcohol dependence. As they will be inpatients and under 24 hour medical care for the first 21 days of treatment, or receiving outpatient treatment through the Alcohol Research and Treatment Clinic, this will allow for a comprehensive assessment of the safety of varenicline in this population with minimal risk of adverse consequences. The patients will continue their cessation treatment for an additional 10 weeks as outpatients through the Nicotine Dependence Clinic at CAMH. They will also be contacted at 6 months for follow-up.
详细描述
Drinking alcohol and cigarette smoking are closely associated and use of one often leads to the use of the other. Also, since tobacco-related illness is the number one cause of death among recovered alcoholics it is imperative that we provide strong evidence-based treatment options for this population. Since smoking can be a strong trigger to drink in those who are dependent on both alcohol and tobacco, treating both at the same time may result in better treatment outcomes. This study will examine the efficacy of starting smoking cessation treatment while patients are in residential treatment for alcohol dependence, or outpatient in the Alcohol Research and Treatment Clinic. It will compare the effectiveness of varenicline, the most effective medication for smoking cessation with placebo. Both groups will receive weekly cessation counselling and support by a trained research analyst. We will measure abstinence from smoking at the end of the 12-week treatment period and again after 6-months to determine longer-term smoking cessation.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •current daily smokers enrolled in residential treatment or outpatient in Alcohol Treatment and Research Clinic for Alcohol Use Disorder at CAMH
- •smoke minimum of 10 cigarettes per day
- •Fagerstrom Test of Nicotine Dependence score > 3
- •able to provide written informed consent
- •able and willing to attend weekly appointments at the NDC following discharge
排除标准
- •any serious medical condition requiring immediate investigation or treatment
- •pregnancy or lactation
- •current DSM-IV Axis I psychiatric disorder
- •any know contraindication to using varenicline
研究组 & 干预措施
varenicline group
干预措施: varenicline (Drug)
placebo group
干预措施: placebo (Drug)
结局指标
主要结局
quit smoking rating
时间窗: end of 12-week treatment
7-day point prevalence
次要结局
- 30 day continuous smoking abstinence(6-month follow-up)
研究者
Laurie Zawertailo
Independent Scientist
Centre for Addiction and Mental Health